Web14 feb. 2024 · Marksans Pharma Ltd. investor presentations, annual reports, calls Competitors/Peers Quarterly Results Annual Results Balance Sheet Financial Ratios … Web28 mrt. 2024 · Ajanta Pharma Q2 Results: Profit dips 20% YoY to Rs 156.6 crore. The company had posted a consolidated net profit of Rs 195.94 crore in the same period last fiscal, Ajanta Pharma said in a regulatory filing.Consolidated revenue from operations stood at Rs 938.1 crore, as against Rs 884.8 crore in the year-ago period.
Marksans Pharma Share Price, Financials and Stock Analysis
WebMarksans Pharma manufactures and markets analgesics, expectorants, anti-diabetic, cardiovascular, central nervous system, gastrointestinal and oncologic drugs as well as … Web10 aug. 2024 · Analyse Income statement, Cashflow statement and balance sheet of Marksans Pharma . Marksans Pharma Ltd annual reports and investor presentations … hobby uri in germana
Marksans Pharma Ltd Share Price Today - Tickertape
WebMarksans Pharma Ltd Share Price Today - Get Marksans Pharma Ltd Share price LIVE on NSE/BSE and Price Chart, News, Announcements, Company Profile, Financial … WebMarksans Pharma Ltd. - Annual reports for 2024, 2024, 2024 and 10 more years MARKETS MARKSANS PHARMA LTD. SECTOR : PHARMACEUTICALS & … Web1 okt. 2024 · AMAL LTD (506597) (149) (Face Value Rs ... Engineering Limited Company brochures, posters, annual reports manuals, etc. Mr. Satishkumar R. Gajjar Backed by a team of qualified and skilled pro- Aged 54 years, He is the Promoter, Man-aging Director & Chief ... Marksans Pharma (Rs. 29.00) (Code: 524404) : ... hsmxpress tutorial